Chat with us
Research Assistance
Online
  • Please enter your first name.

India Platelet Rich Plasma (Prp) Market Size & Outlook

The platelet rich plasma (prp) market in India is expected to reach a projected revenue of US$ 118.2 million by 2033. A compound annual growth rate of 15.9% is expected of India platelet rich plasma (prp) market from 2026 to 2033.

  • Pharmaceuticals
    • Blood Disorders Treatment
      • Platelet Rich Plasma (PRP) Market Outlook
Revenue, 2025 (US$M)
$36.3
Estimate, 2026 (US$M)
$42.0
Forecast, 2033 (US$M)
$118.2
CAGR, 2026 - 2033
15.9%
India Platelet Rich Plasma (Prp) Market, 2021-2033 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Prism AI by Grand View ResearchFree to try

Ask a question about the platelet rich plasma (prp) market

Every figure cited from GVR research

India platelet rich plasma (prp) market highlights

  • The India platelet rich plasma (prp) market generated a revenue of USD 36.3 million in 2025 and is expected to reach USD 118.2 million by 2033.
  • The India market is expected to grow at a CAGR of 15.9% from 2026 to 2033.
  • In terms of segment, pure prp was the largest revenue generating type in 2025.
  • Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.


Platelet rich plasma (prp) market data book summary

Market revenue in 2025USD 36.3 million
Market revenue in 2033USD 118.2 million
Growth rate15.9% (CAGR from 2026 to 2033)
Largest segmentPure prp
Fastest growing segmentLeukocyte Rich PRP
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationPure PRP, Leukocyte Rich PRP, Others Type
Key market players worldwideJohnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences


Other key industry trends

  • In terms of revenue, India accounted for 5.6% of the platelet rich plasma (prp) market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, India platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2033.
  • Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 97.6 million by 2033.

The demand for PRP therapy has grown significantly, particularly among patients experiencing hair loss and skin issues such as pigmentation & ulcers. Over the past few years, the popularity of PRP therapy has surged due to its favorable results and minimal adverse effects. In some hospitals, the Outpatient Departments (OPD) of dermatology or skin branches see an influx of 30 to 40 patients seeking PRP treatment.

The therapy has garnered widespread acceptance, supported by extensive global research. Patients in need of this treatment are recommended and often choose PRP therapy, although alternative treatments are available as well in some cases.

This trend is particularly notable in hospitals in India. Moreover, the Department of Spine, Pain, and Palliative Care at Central Hospital South Eastern Railway began utilizing PRP therapy to treat conditions, such as partial supraspinatus tear in the right shoulder joint. This introduction of PRP therapy within the Indian Railways system signifies an emerging opportunity and potential market growth for its applications in diverse medical fields and patient needs.

No credit card required*

Publish Date: Feb 11, 2026

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Platelet Rich Plasma (PRP) Market Companies

NameProfile# EmployeesHQWebsite
Johnson & JohnsonView profile 134,400One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933www.jnj.com
Stryker CorpView profile 52,0001941 Stryker Way, Portage, MI, United States, 49002www.stryker.com
Zimmer Biomet Holdings IncView profile 18,000345 East Main Street, Warsaw, IN, United States, 46580www.zimmerbiomet.com
Terumo CorpView profile 30,2072-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072www.terumo.com
ArthrexView profile 5001-10000Naples, Florida, United States, North Americawww.arthrex.com/
EmCyte CorporationView profile 11-50Fort Myers, Florida, United States, North Americaemcyte.com/
Dr. PRP USAView profile 11-50Stafford, Texas, United States, North Americawww.drprpusa.com
Juventix Regenerative MedicalView profile 11-50Tampa, Florida, United States, North Americajuventix.com/
APEX BiologixView profile 11-50Murray, Utah, United States, North Americaapexbiologix.com
Celling BiosciencesView profile ---

India Platelet Rich Plasma (PRP) Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Platelet Rich Plasma (PRP) Market Outlook will help companies and investors design strategic landscapes.


Pure Prp was the largest segment with a revenue share of 57.58% in 2025.

Horizon Databook has segmented the India platelet rich plasma (prp) market based on pure prp, leukocyte rich prp, others type covering the revenue growth of each sub-segment from 2021 to 2033.




The demand for PRP therapy has grown significantly, particularly among patients experiencing hair loss and skin issues such as pigmentation & ulcers. Over the past few years, the popularity of PRP therapy has surged due to its favorable results and minimal adverse effects. In some hospitals, the Outpatient Departments (OPD) of dermatology or skin branches see an influx of 30 to 40 patients seeking PRP treatment.

The therapy has garnered widespread acceptance, supported by extensive global research. Patients in need of this treatment are recommended and often choose PRP therapy, although alternative treatments are available as well in some cases.

This trend is particularly notable in hospitals in India. Moreover, the Department of Spine, Pain, and Palliative Care at Central Hospital South Eastern Railway began utilizing PRP therapy to treat conditions, such as partial supraspinatus tear in the right shoulder joint. This introduction of PRP therapy within the Indian Railways system signifies an emerging opportunity and potential market growth for its applications in diverse medical fields and patient needs.

  • India Platelet Rich Plasma (Prp) Market Type Outlook (Revenue, USD Million , 2021-2033)
    • Pure PRP
    • Leukocyte Rich PRP
    • Others Type
  • India Platelet Rich Plasma (Prp) Market Application Outlook (Revenue, USD Million , 2021-2033)
    • Orthopedics
    • Sports Medicine
    • Cosmetic Surgery
    • Dermatology
    • Ophthalmic Surgery
    • Neurosurgery
    • General Surgery
    • Others Application
  • India Platelet Rich Plasma (Prp) Market End Use Outlook (Revenue, USD Million , 2021-2033)
    • Hospitals
    • Clinics
    • Others End Use

Reasons to subscribe to Platelet Rich Plasma (PRP) Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Platelet Rich Plasma (PRP) Market Outlook databook

  • Our clientele includes a mix of Platelet Rich Plasma (PRP) Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the India Platelet Rich Plasma (PRP) Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into India Platelet Rich Plasma (PRP) Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

India Platelet Rich Plasma (Prp) Market, 2021-2033 (US$M)

No Access Stack Chart

India platelet rich plasma (prp) market statistics, by type, 2021-2033 (US$M)

No Access Pie Chart

India platelet rich plasma (prp) market statistics, by type, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more